|
HS Code |
268026 |
| Generic Name | Clindamycin Hydrochloride |
| Brand Names | Cleocin, Dalacin |
| Drug Class | Lincosamide antibiotic |
| Formulation | Capsules, solution for injection, topical gel, cream |
| Route Of Administration | Oral, intravenous, intramuscular, topical |
| Mechanism Of Action | Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit |
| Indications | Bacterial infections, including respiratory tract, skin, soft tissue, bone, and joint infections |
| Common Side Effects | Diarrhea, nausea, abdominal pain, rash |
| Pregnancy Category | Category B (US) |
| Storage Conditions | Store at room temperature, away from moisture and heat |
| Prescription Status | Prescription only |
| Appearance | White or almost white powder |
| Chemical Formula | C18H34ClN2O5S |
| Molecular Weight | 424.0 g/mol |
| Atc Code | J01FF01 |
As an accredited Clindamycin Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Clindamycin Hydrochloride packaging: white plastic bottle, tamper-evident cap, labeled, contains 100 tablets (150 mg each), store at room temperature. |
| Shipping | Clindamycin Hydrochloride should be shipped in tightly sealed containers, protected from light and moisture. Transport at controlled room temperature (15–30°C), unless otherwise specified. Ensure clear labeling as a pharmaceutical or chemical product, following all regulatory guidelines for handling and documentation. Avoid exposure to extreme temperatures during transit. |
| Storage | Clindamycin Hydrochloride should be stored in a tightly closed container, protected from light and moisture. Keep it at controlled room temperature, typically between 20°C and 25°C (68°F and 77°F). Avoid exposure to excessive heat and humidity, and always store away from incompatible substances. Ensure the storage area is secure, well-ventilated, and compliant with relevant safety regulations. |
|
Purity 98%: Clindamycin Hydrochloride with purity 98% is used in pharmaceutical injections, where it ensures effective antibacterial activity against susceptible pathogens. Molecular Weight 461.45 g/mol: Clindamycin Hydrochloride with molecular weight 461.45 g/mol is used in oral capsule formulations, where it delivers accurate dosing for systemic infections. Stability Temperature 25°C: Clindamycin Hydrochloride stable at 25°C is used in long-term bulk storage, where it maintains chemical integrity and therapeutic efficacy. Melting Point 154-158°C: Clindamycin Hydrochloride with melting point 154-158°C is used in active pharmaceutical ingredient manufacturing, where it supports consistent processing and formulation. Particle Size D90 ≤ 30 µm: Clindamycin Hydrochloride with particle size D90 ≤ 30 µm is used in topical gel production, where it enhances homogeneous dispersion and skin absorption. Water Content ≤ 1.0%: Clindamycin Hydrochloride with water content ≤ 1.0% is used in lyophilized powder for reconstitution, where it prevents product degradation and extends shelf life. Solubility in Water 50 mg/mL: Clindamycin Hydrochloride with solubility in water 50 mg/mL is used in intravenous infusion solutions, where it ensures rapid delivery and bioavailability. Residual Solvent < 0.5%: Clindamycin Hydrochloride with residual solvent < 0.5% is used in sterile formulation processes, where it minimizes toxicity risks and complies with regulatory requirements. Assay ≥ 99%: Clindamycin Hydrochloride with assay ≥ 99% is used in high-potency injectable products, where it guarantees therapeutic dose consistency. pH 4.5–6.5 (1% Solution): Clindamycin Hydrochloride at pH 4.5–6.5 (1% solution) is used in ophthalmic preparations, where it promotes ocular safety and stability. |
Competitive Clindamycin Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Stubborn bacterial infections can derail anyone’s routine, no matter your health goals or plans for staying on track. A lot of solutions exist, but not all are up to the challenge. Clindamycin Hydrochloride has stepped in where others flag, earning its place as a strong choice for doctors dealing with difficult cases like bone infections, serious respiratory issues, or aggressive skin infections. From years spent covering medicine and interviewing infectious disease doctors, I’ve seen how this drug changes options in the clinic — especially as resistance to other antibiotics keeps rising.
Clindamycin Hydrochloride comes in a few forms, most commonly as capsules and injectable vials. The capsules often contain 150mg or 300mg of the active compound, tightly packed for reliable dosing. Hospitals also rely on sterile injectable solutions, allowing immediate delivery to patients who can't swallow pills or face critical infection. Getting the active ingredient into the body quickly matters, and this form handles emergencies well. The hydrochloride salt keeps the molecule stable, dissolves easily in water, and ensures accurate absorption — vital traits for trusted medical products.
While some antibiotics struggle with unpredictable absorption in the gut, Clindamycin Hydrochloride works reliably when taken orally. I’ve sat with pharmacists who appreciate this kind of predictability; hospitals track response time in the first 24 hours, and you notice a difference when outcomes match expectations.
Doctors usually reach for Clindamycin Hydrochloride to treat serious infections caused by bacteria that have learned to shrug off simpler drugs. These can include bone (osteomyelitis), severe soft tissue infections, dental abscesses, and certain lung infections. In the world of outpatient clinics and surgical recovery wards, physicians say they value the way Clindamycin Hydrochloride tackles complicated abscesses and infections involving MRSA (methicillin-resistant Staphylococcus aureus — a big name, but an even bigger hospital problem). For patients with penicillin allergies, it often serves as a crucial alternative, broadening the safety net for those who can’t tolerate beta-lactam antibiotics.
The drug doesn’t work for viral infections, nor does it play a starring role for milder illnesses, but for entrenched bacterial cases, patients and medical teams appreciate its reliability. Some clinics have moved away from older antibiotics simply because resistance patterns shifted so much; Clindamycin Hydrochloride remains in the spotlight for its active coverage of tricky bacteria, particularly Gram-positive types.
Comparing antibiotics is never quite apples to apples, but there are practical differences that come up again and again. Take penicillin, for example: it gets neutralized easily by beta-lactamases produced by certain bacteria. Clindamycin Hydrochloride bypasses that defense and keeps working. It also zeroes in on anaerobic bacteria (the type that can thrive in wounds where blood flow is low), making it highly useful in dental practice, deep tissue infections, and post-surgical care. I’ve heard stories from oral surgeons who use it regularly for severe jaw infections, or from ICU physicians who deploy it when other regimens fall flat.
Macrolide antibiotics (such as erythromycin or azithromycin) sometimes get used instead, but Clindamycin Hydrochloride often picks up where they fail. Its tissue penetration runs deeper — literally. This quality helps reach pockets of infection in bone or abscesses, giving it a unique place in orthopedic and surgical wards.
The biggest difference patients notice is digestibility. Some antibiotics create more gastrointestinal side effects, while Clindamycin Hydrochloride can contribute to its own sort of trouble — namely by affecting gut bacteria and, in rare cases, leading to C. difficile infections. Doctors know this risk, so they choose carefully, weighing the benefits against side effects based on the case in front of them. From discussion with infectious disease teams, I've found that Clindamycin Hydrochloride works best under close supervision, particularly for patients with additional risk factors.
The importance of careful antibiotic selection goes beyond the patient sitting in the office or hospital bed today. Using agents like Clindamycin Hydrochloride for the right reasons — not as a casual fallback for every sore throat or bite wound — helps preserve its strength. Overuse and misuse fuel resistance, unraveling the progress made over decades. The struggle against antibiotic resistance doesn’t just happen in government reports or academic journals. It shows up in the everyday stories of families whose common infections become hard to treat, or in the pressure felt by doctors working without enough options.
Health authorities like the WHO and CDC have tracked the spread of resistance among Gram-positive bacteria for years, and Clindamycin Hydrochloride remains one of the few weapons that haven't lost full power, although some strains have begun pushing back. That makes careful dosing and strict prescription practices essential. As I’ve listened to antibiotic stewardship meetings in hospitals, this drug’s value is always part of the calculus: keeping it potent for those who genuinely need it.
Normal practice sees adults start on 150-450mg taken three or four times a day, depending on severity and infection type. Children get tailored doses using weight as the main guide. Intravenous forms pick up during severe cases, giving quick, efficient blood levels. The right timing and duration matter — stop too soon, and bacteria can roar back. Go too long, and side effects escalate without added benefit. Above all, complete courses stop diseases from lingering and evolving resistance.
Patients sometimes feel tempted to stop early when symptoms fade, but the bacteria can hide stronger than before. Community health efforts have tried to educate people on completing their regimen, and pharmacists often reinforce the message face-to-face. It’s always a partnership between patient, physician, and the larger health system to keep antibiotics like Clindamycin Hydrochloride useful into the next decade and beyond.
No medication comes without risk. The most common issues with Clindamycin Hydrochloride include nausea, diarrhea, and occasional abdominal pain. Recently, experts and medical literature have spotlighted the link between this drug and C. difficile-associated diarrhea — a gut infection that requires prompt treatment in its own right. In my experience reporting on hospital outbreaks, this challenge prompted many hospitals to review protocols and train staff on early recognition and prevention.
Allergic reactions remain rare but serious, and blood count changes or liver function troubles can emerge, particularly for people on longer courses. Responsible clinicians keep a close watch, checking in with patients and the lab if therapy extends beyond a week. Hospitals often have systems in place that alert pharmacists to potential overuse or dangerous interactions, keeping everyone safer.
Certain patient groups face higher risk and see more caution. People with a record of C. difficile or other chronic gastrointestinal illnesses need careful evaluation before getting this drug. The same careful approach applies to anyone with liver issues, pregnant or breastfeeding individuals, and those taking multiple other medications that may interact. Experienced infectious disease doctors usually weigh all these variables, making every prescription a custom order rather than a cookie-cutter formula.
While most patients never touch the supply chain side, those working in hospital pharmacies or drug distribution centers pay close attention to correct temperature and light exposure. Both capsules and vials hold up well at room temperature if kept dry and shielded from sunlight. Once reconstituted, injectable solutions require prompt use, with any unused portions discarded to stop contamination before it starts. In outpatient clinics, practical storage guidance forms a big part of medication teaching for both staff and patients, promoting safety from manufacturer to bedside.
The search for effective, targeted antibiotics grows every year, especially as superbugs gain ground. Clindamycin Hydrochloride remains on the front line thanks to its active profile against serious Gram-positive and anaerobic bacteria, its oral and intravenous versatility, and strong records in tough infections. I’ve seen the real-life results: patients turning corners after long struggles, or families relieved when alternatives fail. This drug isn’t a miracle cure, but its well-documented performance and decades of careful clinical observation keep it in the toolkit for the foreseeable future.
Colleagues in rural health centers appreciate Clindamycin Hydrochloride for handling cases that might otherwise require transfer to major hospitals. In parts of the world where certain antibiotics have faltered entirely, it holds a critical place. Still, everybody — prescriber, pharmacist, and patient — shares responsibility for preserving its strength. The cycle repeats: effective care, completed courses, and ongoing vigilance against unnecessary prescriptions.
Antibiotics like Clindamycin Hydrochloride bring both hope and responsibility. With smart stewardship, honest patient education, and robust monitoring, this medication will keep providing options for complicated infections when so much else fails. Conversations with primary care physicians and hospitalists show a consistent respect for its action, tempered by caution born from experience. No drug works in isolation: its future value rests in the choices made by today’s clinicians, policy-makers, and — crucially — every patient who swallows a prescribed dose.
For patients, understanding how Clindamycin Hydrochloride fits into treatment empowers more than just individual recovery. It shapes the way society guards antibiotics for collective good. That’s why interviews, medical conferences, and patient education programs always include a call to stick with treatment instructions, signal new symptoms early, and ask questions if uncertainty arises. From big hospitals to local clinics, every link in the chain magnifies the positive impact of judicious antibiotic use.
Medical societies consistently recommend regular updates to treatment guidelines, including local and regional resistance patterns. This data helps practitioners choose Clindamycin Hydrochloride only for situations where benefits outweigh risks. Hospitals have expanded surveillance teams, reviewing prescriptions in real time, offering feedback, and sharing lessons in staff meetings. Pharmacies now educate patients more deeply, using leaflets, counseling sessions, and regular follow-ups. Anything short of full engagement fails to protect these vital therapies for future generations.
Patients can support these goals by understanding their prescription, reporting all medicines taken, following the schedule, and speaking up if something feels off. Clear communication as a two-way street stands out as a core lesson from decades reporting on medicine — it deals with confusion, catches early side effects, and fosters trust that keeps adherence strong. Families affected by resistant bacteria know the stakes are high and value every advantage a carefully-chosen antibiotic can bring.
As bacteria continue to adapt, medical teams lean on trusted antibiotics that perform under pressure, reach difficult infection sites, and stay active against key pathogens. Clindamycin Hydrochloride checks these boxes. Its role becomes even clearer against a backdrop of increasing resistance to older agents. In surgical wards, dental clinics, and community clinics alike, the medication’s practical features — reliability, reach, and manageable dosing — make a difference where it counts.
In conclusion, every choice around Clindamycin Hydrochloride reflects wider principles: using evidence-based practice, acknowledging uncertainties, educating everyone involved in the medication journey, and collaborating across disciplines. Careful, honest stewardship keeps precious antibiotics working, saves lives, and forms the backbone of smarter healthcare systems. All of us — whether inside the hospital or out — share in the success story of every infection turned around with the right antibiotic, at the right dose, for the right reason.